So as way of background, EZH2 is an epigenetic enzyme that's overexpressed in castrate-resistant prostate cancer, and it's ...

Through a mouse study, scientists have found that aspirin may help prevent metastases, or secondary tumors, by boosting the ...

A short course of androgen deprivation therapy (ADT) added to stereotactic body radiotherapy (SBRT) halved the risk of ...

The first patient has been enrolled in the phase 3 PROSTATE-IQ trial being conducted in men with prostate cancer recurrence ...

The global market for prostate cancer market is likely to be valued at around USD 12.9 billion in 2025 and is projected to ...

U.S. deaths in 2024. 1.4 million new cases worldwide in 2022. Prostate cancer statistics can look scary: 34,250 U.S. deaths in 2024. 1.4 million new cases worldwide in 2022. Dr. Bruce Montgomery, a UW ...

U.S. deaths in 2024. 1.4 million new cases worldwide in 2022. Dr. Bruce Montgomery, a UW Medicine oncologist, hopes that ...

Prostate cancer affects one in eight men during their lifetime, making it the second most common cancer among American males.

Two new drugs to treat prostate and liver cancer have been given the green light for use by the NHS in Scotland. The Scottish ...

Novartis Pharmaceuticals Canada Inc. (Novartis) welcomes the Government of Alberta's decision to publicly reimburse Pluvicto™ (lutetium (177Lu) vipivotide tetraxetan injection) for eligible patients ...

Healthy lifestyle and dietary choices are associated with a reduction in the risk of all-cause death among patients with non-metastatic prostate cancer, researchers found.